Logo image of ALVR

ALLOVIR INC (ALVR) Stock News

NASDAQ:ALVR - Nasdaq - US0198181036 - Common Stock - Currency: USD

9.81  +0.15 (+1.55%)

ALVR Latest News, Press Relases and Analysis

News Image
a month ago - AlloVir, Inc.

Kalaris and AlloVir Announce Stockholder Approval of Merger

Combined company expected to trade on Nasdaq under “KLRS” after closing...

News Image
9 months ago - BusinessInsider

ALVR Stock Earnings: AlloVir Beats EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips AlloVir (NASDAQ:ALVR) just reported results for the second quarter of 2024.Allo...

News Image
9 months ago - InvestorPlace

ALVR Stock Earnings: AlloVir Beats EPS for Q2 2024

ALVR stock results show that AlloVir beat analyst estimates for earnings per share the second quarter of 2024.

News Image
a year ago - InvestorPlace

ALVR Stock Earnings: AlloVir Misses EPS for Q1 2024

ALVR stock results show that AlloVir missed analyst estimates for earnings per share the first quarter of 2024.

News Image
6 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of Shareholders

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: EMKR

News Image
6 months ago - AlloVir, Inc.

AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina

Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a novel, differentiated and...

News Image
a year ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR). The class...